Early treatment of thrombotic microangiopathy,a rare and serious complication after heart transplant |
| |
| Affiliation: | 1. Division of Cardiology, Department of Pediatrics, Hospital for Sick Children, Toronto, Ontario, Canada;2. Division of Nephrology, Department of Pediatrics, Hospital for Sick Children, Toronto, Ontario, Canada;3. Division of Cardiology, Department of Critical Care Medicine, Hospital for Sick Children, Toronto, Ontario, Canada;4. Temerty Faculty of Medicine, University of Toronto, Ontario, Canada;1. Queensland Lung Transplant Service, The Prince Charles Hospital, Brisbane, Australia;2. School of Medicine, The University of Queensland, Brisbane, Australia;3. The University of Queensland, Diamantina Institute, The University of Queensland, Wooloongabba, Australia;4. Australian Infectious Diseases Research Centre, University of Queensland, Brisbane, Australia;1. Toronto Lung Transplant Program, University Health Network, University of Toronto, Toronto, Ontario, Canada;2. Institute of Pulmonary Medicine, Sheba Medical Center, Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel;3. Biostatistics Research Unit, University Health Network, University of Toronto, Toronto, Ontario, Canada;1. Division of Cardiovascular Medicine, The Ohio State University Wexner Medical Center, Columbus, Ohio;2. Division of Cardiovascular Medicine, Stanford University Medical Center, Palo Alto, California;3. Division of Cardiovascular Medicine, Henry Ford Health System, Detroit, Michigan;4. Division of Cardiac Surgery, The Ohio State University Wexner Medical Center, Columbus, Ohio;5. Kirklin Institute for Research in Surgical Outcomes, University of Alabama, Birmingham, Alabama;6. Division of Cardiac Surgery, Stanford University Medical Center, Palo Alto, California;7. Division of Cardiac Surgery, University of Michigan Medical Center, Ann Arbor, Michigan;1. Division of Pulmonary and Critical Care, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore;2. Columbus State University, Columbus, Georgia;3. Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore;4. National Cancer Institute, National Institutes of Health, Rockville, Maryland;5. Genomic Research Alliance for Transplantation (GRAfT), Bethesda, Maryland;6. Department of Medicine, University of Maryland, College Park, Maryland;7. Advanced Lung Disease and Transplant Program, Inova Heart and Vascular Institute, Inova Fairfax Hospital, Falls Church, Virginia;8. National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland;1. Division of Cardiology, Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, New York;2. Division of Infectious Diseases, Department of Internal Medicine, Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, New York;3. Department of Cardiothoracic and Vascular Surgery, Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, New York;1. Leviev Cardiothoracic and Vascular Center, Sheba Medical Center, and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel;2. Department of Transplantation, Royal Papworth Hospital NHS Foundation Trust, Cambridge Biomedical Campus, Cambridge;3. Department of Cardiology, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California |
| |
| Abstract: | |
| |
| Keywords: | |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
